As the number of new hepatitis C virus infections continues to rise in the United States, rapid diagnosis and treatment of high-risk patients is more important than ever. In this Q&A, Benjamin Eckhardt, MD,...
The researchers investigated 4-week prophylaxis combination therapy before and after kidney transplantation between donors and recipients with HCV. Lead author Christine M. Durand, MD, answered our...
A new study has indicated that the transplantation of HCV-positive livers into HCV-negative individuals may be a viable option in the era of direct-acting antiviral therapy. Consultant360 discussed the...
